Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,732 | -13,650 | -22,960 | N/A | -27,415 |
| Depreciation Amortization | 4,479 | 3,718 | 2,883 | N/A | 3,247 |
| Other Working Capital | 789 | -10,502 | -280 | N/A | 1,120 |
| Operating Cash Flow | $-16,464 | $-20,434 | $-20,357 | $N/A | $-23,048 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,727 | -1,565 | -1,124 | N/A | -565 |
| Other Investing Activity | -35,818 | -6,177 | 19,937 | 0 | -69,369 |
| Investing Cash Flow | $-39,545 | $-7,742 | $18,813 | $N/A | $-69,934 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 160,573 | 156,799 | 157,042 | 0 | 89,992 |
| Financing Cash Flow | $160,573 | $156,799 | $157,042 | $N/A | $89,992 |
| Beginning Cash Position | 27,420 | 27,420 | 27,420 | N/A | 30,410 |
| End Cash Position | 131,984 | 156,043 | 182,918 | N/A | 27,420 |
| Net Cash Flow | $104,564 | $128,623 | $155,498 | $N/A | $-2,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,464 | -20,434 | -20,357 | N/A | -23,048 |
| Free Cash Flow | -16,464 | -20,434 | -20,357 | 0 | -23,048 |